Ionic Rare Earths targets AIM listing as Belfast magnet recycling strategy gathers pace
Ionic Rare Earths Ltd (ASX:IXR, OTC:IXRRF) is advancing plans to list its shares on London's AIM market in the fourth quarter of 2026 as it builds its UK presence and progresses commercialisation of its rare earth magnet recycling technology. The proposed AIM admission would complement IonicRE's existing ASX listing and is expected to broaden the company's access to UK and European investors with an interest in critical minerals and the energy transition.
Ondine Biomedical pauses trading to raise fresh investment after positive phase III result
Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF), the developer of light-activated nasal disinfection for hospital patients, has suspended trading in its shares while it raises new investment to capitalise on its clinical and commercial progress. The company is one of a growing band of growth companies to use AIM's new Capital Access Window, a voluntary pause in share trading designed to widen the pool of investors and keep the price stable during a fundraise.
1947 Oil & Gas starts AIM trading after £50m fundraising and Gulf acquisition
1947 Oil & Gas, a newly listed oil and gas producer focused on US assets, began trading on London's AIM market on Monday with an initial valuation of about £65 million. The company issued 500 million shares at 10p each, raising £50 million through a combination of shares issued to the vendor of Renaissance Offshore and a placing with new investors.
1947 Oil & Gas makes AIM debut with ambitions to grow production sharply in coming years
1947 Oil & Gas PLC (AIM:1947) begins trading on AIM today, with shares marked at a premium price and ambitions to lift production from its newly acquired US Gulf of America assets by around 50% over the next two years. In its London IPO, the junior oil and gas raised roughly £30 million at 10p a share to help fund its US$65 million acquisition of Houston-based Renaissance Offshore.
Coiled Therapeutics fills two cohorts as reworked cancer drug advances
Coiled Therapeutics (AIM:COIL, OTCQB:COTXF) has enrolled the first patients into two dose groups testing a reformulated version of its experimental cancer drug. The AIM-listed oncology group said it had signed up three patients each to a twice-daily 120mg cohort and a once-daily 160mg cohort of AO-252, its lead treatment.
Kefi confirms staff safe after fatal Tulu Kapi attack as local investors step up
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF, FRA:KMSA), the AIM-listed explorer developing the Tulu Kapi gold project in Ethiopia, said all employees affected by last week's security incident have been accounted for, with no further casualties. One employee was killed and Kefi suspended development at the site after the attack on 4 September.
Sintana Energy advances deal to acquire KON-16 in Angola
Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) has signed definitive agreements for its proposed entry into Angola's Block KON-16, securing an indirect 5% participating interest as the partners work towards a pre-salt exploration well in 2027. The company will pay US$2.5 million for the interest, including US$500,000 already paid to Corcel PLC (AIM:CRCL, FRA:RM4B) and a further US$2 million due on completion.
Ondine Biomedical strikes deal with Mexico's largest private hospital network
Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF), the AIM-listed company behind light-activated antimicrobial therapies, has agreed a partnership with Hospital Ángeles, Mexico's largest private healthcare network, to pilot its Steriwave nasal photodisinfection treatment. The multi-centre pilot follows positive results from Ondine's phase III trial of 5,188 patients across Canadian and US hospitals, which showed a 40% reduction in post-surgical infection rates compared with standard care.
Metals One partner rejects claim that Barbrook mine deal has failed
Lions Bay Resources has rejected a claim by Vantage Goldfields that its proposed acquisition of the Barbrook gold mine in South Africa has failed, describing the statement as false and misleading. The company is owned by Metals One PLC (AIM:MET1, FRA:HT7, OTCQB:MTOPF), the AIM-listed mining company, and Lions Bay Capital, which trades on the TSX Venture Exchange.
Alien Metals shares rise 4% after bonanza-grade silver results
Shares in Alien Metals Ltd (AIM:UFO, OTC:ASLRF), the AIM-listed minerals exploration and development company, rose 4% to 0.10p on Thursday. The move followed diamond drilling results from the Elizabeth Hill Silver Project in Western Australia, announced by joint venture partner West Coast Silver, which is listed on the Australian Securities Exchange.
Thruvision shares rise over 14% after Canadian government order
Shares in Thruvision Group PLC (AIM:THRU, OTC:DIGTF), the walk-through security screening company listed on AIM, rose 14% to 1.40p on Thursday. The move followed news of a new order in Canada, marking Thruvision's first government customer in the country and its first deployment in Canada's entrance security market.
Tower Resources tops up working capital as farm-out moves closer to completion
Tower Resources PLC (AIM:TRP, FRA:ULF1) has raised £325,000 of additional working capital as it moves closer to completing farm-out transactions in Namibia and Cameroon that are expected to unlock further funding. The AIM-listed group issued around 2.36 billion shares at 0.01375p each, an approximately 8% discount to Friday's closing bid price.
